Loading company…
Shenzhen Uni-medica Technology provides genetic testing for newborns and children, using its own sequencing and diagnostic platforms.
Established in 2011 and based in Shenzhen, China, Uni-medica develops high-throughput sequencing, fluorescence PCR, fluorescence microscopy, flow cytometry platforms and rapid detection reagents. Its neonatal genetic and metabolic disease test, Bekekang, is part of its high-throughput sequencing offering. The company has partnerships with the Chinese Academy of Sciences, Wuhan Institute of Virus Research, Shenzhen University, Hong Kong University, Shenzhen Center for Disease Control and Prevention and Shanghai Children's Hospital. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in